Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 21, 2015 9:36 AM ET

Pharmaceuticals

Company Overview of MSD K.K.

Executive Profile

David Westbrook Anstice

Independent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee, Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 5 different industries.

See Board Relationships
66$563,393

Background

Mr. David Westbrook Anstice served as the President of MSD K.K. Mr. Anstice served as Executive Vice President of Strategy Initiatives at Merck & Co. Inc., from September 2006 to September 2008. He served as the President of Human Health of Merck & Co., Inc. from January 2003 to September 2006 and was responsible for its prescription drug business in Japan, Latin America, Canada, Australia, New Zealand and its joint venture relationship with Schering-Plough. He spent ...

Corporate Headquarters

Kitanomaru Square
Tokyo, -- 102-8667

Japan

Phone: 81 3 6272 1000
Fax: 81 3 6238 9057

Board Members Memberships

Representative Director
Trustee
Director
2008-Present
Independent Director, Chairman of Compensation Committee and Member of Limited Compensation Sub Committee
2008-Present
Independent Director, Member of Nomination Committee, Member of Human Resources & Remuneration Committee and Member of Innovation & Development Committee
2008-Present
Director

Education

Bachelor's Degree 1970
University Of Sydney

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$94,000
Total Calculated Compensation$563,393
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
$916.2K
Herve Hoppenot Chief Executive Officer, President, Director and Member of Non-Management Stock Option Committee
Incyte Corporation
$2.9M
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$620.1K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
$1.2M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MSD K.K., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.